Serum albumin measurement in nephrology : room for improvement

© The Author(s) 2020. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved..

Serum albumin is a widely used biomarker in clinical nephrology. Serum albumin cut-off values are used to define disease, to predict outcome and to guide patient care. The available commercial assays to measure serum albumin rely on different analytical principles, all with their own (analytical) specifications. This article provides an overview of the different clinical applications of serum albumin measurements in nephrology, the (dis)advantages of the available assays and the estimates of the effects of the measurement uncertainty between different assays in clinical decision making. This article concludes that harmonization of serum albumin assay results is needed.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:37

Enthalten in:

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association - 37(2022), 10 vom: 22. Sept., Seite 1792-1799

Sprache:

Englisch

Beteiligte Personen:

van Schrojenstein Lantman, Marith [VerfasserIn]
van de Logt, Anne-Els [VerfasserIn]
Thelen, Marc [VerfasserIn]
Wetzels, Jack F [VerfasserIn]
van Berkel, Miranda [VerfasserIn]

Links:

Volltext

Themen:

Clinical decision making
Clinical laboratory techniques
Journal Article
Measurement uncertainty
Nephrology
Serum Albumin
Serum albumin

Anmerkungen:

Date Completed 23.09.2022

Date Revised 26.10.2022

published: Print

Citation Status MEDLINE

doi:

10.1093/ndt/gfaa375

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM319321827